Inhalers for asthma and COPD
Huisarts en Wetenschap, ISSN: 1876-5912, Vol: 57, Issue: 3, Page: 142-147
2014
- 1Citations
- 16Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Inhaled medications for the treatment of asthma and chronic obstructive pulmonary disease (COPD) are administered via inhalers. A large number of inhalers are available, and the general practitioner has to choose between a dry powder inhaler and an aerosol inhaler with or without a spacer, with the choice depending on the abilities and preference of the patient. It may help to assess the following four points: can the patient consciously inhale, can the patient forcefully inhale, can the patient hold his/her breath for 5 seconds, and does the patient have good hand-lung coordination. It makes sense for the patient to use one type of inhaler and not a combination of aerosol inhaler and dry powder inhaler. After the start of a (new) inhaler patients should be asked to visit to check how they use the inhaler after about 6 weeks. The inhaler technique of patients with asthma or COPD and inhaler maintenance should be monitored annually by the practice case manager or, if appropriate, the pharmacy assistant. Incorrect use of an inhaler has a much greater effect on the lung deposition of medication and on symptoms than the type of inhaler used. © 2014 Bohn, Stafleu van Loghum.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84897445240&origin=inward; http://dx.doi.org/10.1007/s12445-014-0070-5; http://link.springer.com/10.1007/s12445-014-0070-5; http://link.springer.com/content/pdf/10.1007/s12445-014-0070-5; http://link.springer.com/content/pdf/10.1007/s12445-014-0070-5.pdf; http://link.springer.com/article/10.1007/s12445-014-0070-5/fulltext.html; https://dx.doi.org/10.1007/s12445-014-0070-5; https://link.springer.com/article/10.1007/s12445-014-0070-5
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know